欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/4319/001
药品名称Carboplatin 10 mg/ml Concentrate for Solution for Infusion
活性成分
    • carboplatin 10.0 mg
剂型Concentrate for solution for infusion
上市许可持有人Fresenius Kabi Nederland BV Amersfoortseweg 10 E 3712BC Huis ter Heide Nederland
参考成员国 - 产品名称Netherlands (NL)
互认成员国 - 产品名称
    • Spain (ES)
    • United Kingdom (Northern Ireland) (XI)
      PL 18727/0025 - 0017
    • Germany (DE)
      Carboplatin Kabi 10 mg/ml Konzentrat zur Herstellung einer Infusionslösung
    • Denmark (DK)
      Carboplatin "Fresenius Kabi"
    • Belgium (BE)
    • Luxembourg (LU)
    • Iceland (IS)
    • Ireland (IE)
    • France (FR)
    • Portugal (PT)
    • Norway (NO)
      Carboplatin Fresenius Kabi
    • Poland (PL)
    • Latvia (LV)
    • Lithuania (LT)
      Carboplatin Kabi 10 mg/ml koncentratas infuziniam tirpalui
    • Estonia (EE)
      CARBOPLATIN KABI 10 MG/ML
    • Hungary (HU)
    • Czechia (CZ)
      Carboplatin Kabi 10 mg/ml koncentrát pro přípravu infuzního roztoku
    • Romania (RO)
      Carboplatin Kabi 10mg/ml concentrat pentru soluţie perfuzabilă
    • Slovakia (SK)
      Carboplatin Kabi 10 mg/ ml
    • Malta (MT)
      Carboplatin 10mg/ml concentrate for solution for infusion
许可日期2012/01/27
最近更新日期2024/01/17
药物ATC编码
    • L01XA02 carboplatin
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：[not specified]
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase